文献速递临床微生物质量管理与危急值

优化哌拉西林-他唑巴坦药敏试验:没那么简单

Building a Better Test for Piperacillin-Tazobactam Susceptibility Testing: Would that It Were So Simple (It's Complicated).
PubMed 文献 · J Clin Microbiol · 2020-01-28

本文评论了García-Fernandez等人对重新配方的哌拉西林-他唑巴坦Etest的性能评估,指出其分析性能优异,但在某些测试敏感的菌株中哌拉西林-他唑巴坦疗效不佳的新数据下,MIC值的价值存在争议。强调需结合肠杆菌目和铜绿假单胞菌的模态MIC、MIC试验变异性及可能的耐药机制来优化该抗菌药的使用。

要点

  • 重新配方的哌拉西林-他唑巴坦Etest分析性能优异。
  • 某些菌株测试敏感但哌拉西林-他唑巴坦疗效不佳,使MIC值价值存争议。
  • 需结合模态MIC、试验变异性和耐药机制优化用药。

核心结论

  • 哌拉西林-他唑巴坦MIC值的临床价值存争议,需结合模态MIC、试验变异性和耐药机制综合解读。

主要发现

  • 重新配方的哌拉西林-他唑巴坦Etest分析性能数据优异。

临床怎么用

  • 评估哌拉西林-他唑巴坦MIC时,应参考肠杆菌目和铜绿假单胞菌的模态MIC及试验变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this issue of the Journal of Clinical Microbiology, S. García-Fernandez, Y. Bala, T. Armstrong, M. Garcia-Castillo, et al. (J Clin Microbiol 58:e01042-19, 2020, https://doi.org/10.1128/JCM.01042-19) describe the performance of a reformulated Etest for piperacillin-tazobactam. The analytical performance data are excellent, but in the face of recent emerging data on the inefficacy of piperacillin-tazobactam for certain organisms that test susceptible, the value of piperacillin-tazobactam MICs is controversial. Evaluation of MICs in the context of the modal MIC for Enterobacterales and Pseudomonas aeruginosa, the variability of MIC tests, and, possibly, resistance mechanisms is important to the optimum use of this antimicrobial.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Henderson A, Humphries R. Building a Better Test for Piperacillin-Tazobactam Susceptibility Testing: Would that It Were So Simple (It's Complicated). J Clin Microbiol. 2020. PMID: 31723014. doi:10.1128/JCM.01649-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。